[The effect of angiotensin receptors and neprilysin inhibitors on myocardial remodeling in patients with chronic heart failure and atrial fibrillation].

Autor:	Uskach TM; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation., Safiullina AA; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation., Makeev MI; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation., Saidova MA; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation., Shariya MA; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation., Ustyuzhanin DV; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation., Zhirov IV; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation., Tereshchenko SN; FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation.
Jazyk:	ruština
Zdroj:	Kardiologiia [Kardiologiia] 2019 Oct 07; Vol. 59 (10S), pp. 64-72. Date of Electronic Publication: 2019 Oct 07.
DOI:	10.18087/cardio.n815
Abstrakt:	Aim: To evaluate the effect of angiotensin-neprilysin receptor inhibitors on myocardial remodeling in patients with chronic heart failure and atrial fibrillation. Materials and Methods: We studied dynamics of the parameters of ultrasound structural and functional parameters of the left atrium and left ventricle of the heart was during 3-month therapy with sacubitryl-valsartan in a group of 15 patients with a combination of chronic heart failure due to dilated and paroxysmal paroxysmal forms of atrial fibrillation. Results: Showed a statistically significant positive effect of the use of angiotensin receptors and neprilysin inhibitors on the parameters of remodeling of the left atrium (according to transthoracic and transesophageal echocardiography), left ventricle, as well as levels of natriuretic peptides ANP and NT-pro-BNP. Conclusion: The use of ARNI may be promising in terms of treatment and prevention of AF in patients with heart failure.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu